APC-Labeled Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Tetramer Protein

Catalog Number: ABS-HL1-HA2H8-200TESTS
Article Name: APC-Labeled Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Tetramer Protein
Biozol Catalog Number: ABS-HL1-HA2H8-200TESTS
Supplier Catalog Number: HL1-HA2H8-200tests
Alternative Catalog Number: ABS-HL1-HA2H8-200TESTS
Manufacturer: AcroBiosystems
Host: Human
Category: Proteine/Peptide
Species Reactivity: Human
Conjugation: APC
NYESO1, which is also wellknown as New York esophageal squamous cell carcinoma 1, is an efficient target for cancer immunotherapy. This antigen is a member of cancertestis antigens (CTAs) and is highly expressed in various cancers, including melanoma, ovarian, cervical cancer, etc. Adoptive T cell therapy with HLAA2 restricted NYESO1 transduced CD8+ T cells has improved the clinical response rates and overall survival of treatmentrefractory melanoma patients. The Human HLAA*0201 NYESO1 (SLLMWITQV) complex protein is a complex of HLAA*0201 of the MHC Class I, B2M and SLLMWITQV peptide of the NYESO1. - Proteine/Peptide
Molecular Weight: 36.3 kDa and 13.8 kDa
Tag: C-10*His
NCBI: 59606
Buffer: 0.2% BSA
Form: Powder
Target: HLA-A*0201 & B2M & NY-ESO-1 (SLLMWITQV)
HL1-HA2H8-200tests